SNEHA PATEL: Open Payments
NPI 1841765880 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 69 payments from 14 companies in 2025. Trend: 2023 $581 · 2024 $695 · 2025 $1,508
Food & beverage: $1,408Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $238 |
| GlaxoSmithKline, LLC. | 15 | $228 |
| Regeneron Healthcare Solutions, Inc. | 6 | $168 |
| Amgen Inc. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 7 | $122 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Optinose US, Inc. | 3 | $58 |
| Lilly USA, LLC | 1 | $23 |
Products named: TEZSPIRE, DUPIXENT, CUVITRU, NUCALA, NEFFY, Xhance, Rhapsido, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
